Skip to main content
OpenTrials
Completed

NCT Number: NCT02245958

A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm

This study is a retrospective chart review to evaluate the doses of botulinum Type A toxins BOTOX® (onabotulinumtoxinA) and Xeomin® (incobotulinumtoxinA) used for the treatment of Cervical Dystonia and Blepharospasm in clinical practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cervical Dystonia Blepharospasm Dyskinesias Dystonia Eye Diseases Eyelid Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Torticollis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Colonia Roma Z.P., Mexico

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed primary diagnosis of idiopathic cervical dystonia or blepharospasm for at least 2 years
  • Treatment with Xeomin® and BOTOX® for at least 2 years each.

Exclusion criteria

  • Having a neuromuscular junction transmission disorder or taking any medications that could affect neuromuscular junction transmission
  • Previous surgical procedure involving bone or muscle for the management of cervical dystonia or blepharospasm.

Treatment and study plan

No intervention

Other

No treatment (intervention) was administered.

Primary outcomes

  1. Dose of Botulinum Toxin Used to Treat Cervical Dystonia

    Time frame: 4 Years

  2. Dose of Botulinum Toxin Used to Treat Blepharospasm

    Time frame: 4 Years

Secondary outcomes

  1. Botulinum Toxin Inter-injection Intervals

    Time frame: 4 Years

  2. Number of Participants with Adverse Events

    Time frame: 4 Years

  3. Annual Botulinum Toxin Dose per Patient

    Time frame: 4 Years

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Sep 22, 2014
Registry last updated
Jan 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.